Financing Raised $30 million in non-dilutive financing via a pre-paid supply agreement with High Park Holdings Ltd.("High Park"), a wholly-owned subsidiary of Tilray, Inc.; Raised $10 million in non-dilutive financing via a pre-paid supply agreement with Starseed Medicinal Inc.("Starseed"); Raised $25 million in new senior secured debt financing; and Announced a rights offering to holders of its common shares that is intended to raise up to $20.8 million, with insiders of Zenabis committing to acquire ~30% of the common shares available under the rights offering for a total of $6.2 million in proceeds.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.